Skip to main content
Fig. 2 | Human Genomics

Fig. 2

From: Genome-based therapeutic interventions for β-type hemoglobinopathies

Fig. 2

Clinical Trials in β-hemoglobinopathies patients using lentiviral vectors (source of data: [76] Assessed 13-11-2020). The total number of results was performed using certain filtering criteria: “Recruitment status: Not yet recruiting OR Recruiting OR Active, not Recruiting,” “Sex status: All,” “Study type: Interventional (Clinical Trial),” Study Phase: Phase 2 OR Phase 3, Period of clinical trial: 2010 to 2020. The asterisk in clinical trials identities: NCT04293185, NCT03207009, NCT02906202 symbolizes that these clinical trials are sponsored by Bluebird Bio and have been accepted to phase 3. In this phase, the recruitment includes an increased number of participants, in different locations and populations.

Back to article page